Brief: Sinopharm Group Gets Informed Listing Committee Criticized Co's Independent Non- Exec Director
Feb 14 (Reuters) - Sinopharm Group Ltd 1099.HK :
* WAS INFORMED THAT LISTING COMMITTEE CRITICIZED AN
INDEPENDENT
NON- EXECUTIVE DIRECTOR OF CO
* MATTERS ARE NOT RELATED TO BUSINESS OPERATIONS OF COMPANY
AND
ITS SUBSIDIARIES AND WILL NOT HAVE ANY IMPACT ON CO
* CONSIDERS MATTERS DO NOT AFFECT CONTINUED SERVICE OF
INDIVIDUAL
AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR OF CO
Source text for Eikon: ID:nHKS6j1XKx
Further company coverage: 1099.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For